AltaCorp analyst Kideckel rates OGI an “Outperform” with 66% return

AltaCorp Capital analyst Kideckel says that derivatives should improve OGI’s growth and margin outlook, as they…

Organigram now licenced for 15,000 kg/year more

Facility Expansion Remains on Schedule to Increase Capacity and Further Improve Efficiencies of Scale MONCTON, New…

Organigram Conditionally Approved to Graduate to the TSX

MONCTON, New Brunswick–(BUSINESS WIRE)– Organigram Holdings Inc. (NASDAQ: OGI) (TSX VENTURE: OGI), the parent company of…